Distributes and blends industrial, water treatment and food/health chemicals for commercial customers.
Distributes and blends industrial, water treatment and food/health chemicals for commercial customers.
Buys chemicals in bulk, stores, blends and delivers them with its own fleet, earning a handling and blending margin. Water-treatment demand is steady since utilities need continuous supply. Growth has come from many small acquisitions.
Moat: narrow (distribution, scale). Regional chemical distribution and blending network with logistics and storage infrastructure that's costly to replicate.
Headquarters: Rosemount, Minnesota, US · Founded: 1938 · Employees: 1,200
Size Hawkins (HWKN) is a United States Materials company (Chemicals: Specialty) with a market value of $3.19B, the 1493rd largest of 3,085 United States companies the cockpit tracks. Shares closed at $153.20 on 18 Nov 2026.
Performance Over six months the shares fell 1.2%, against -25.4% for the median peer and -2.2% for the United States market (cap-weighted) — 4th highest of 21 in its peer set.
Growth Revenue grew 9.0% over the last twelve months (peer median +12.9%); the operating margin is 10.8% (peer median 13.5%).
Valuation It trades at 34.4× forward earnings against a peer median of 17.5× (5th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +13%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.7 points above its cost of capital (8.4% WACC).
Short interest Short interest is 6.2% of the free float (30 Oct 2026).
Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.14B | $1.08B | $974M | $919M | $935M |
| Revenue growth | — | +11% | +6% | -2% | — |
| Gross profit | $256M | $224M | $213M | $194M | $165M |
| EBITDA | $178M | $168M | $160M | $136M | $118M |
| Net income | $85.8M | $81.5M | $84.3M | $75.4M | $60.0M |
| Free cash flow | $92.5M | $86.1M | $70.0M | $119M | $29.1M |
| Capital expenditure | $56.3M | $58.2M | $41.1M | $40.2M | $48.3M |
| Total debt | $244M | $261M | $163M | $108M | $120M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Hawkins HWKN | $3.19B | -1% | +9% | 11% | 34.4× | 15.9% |
| Brenntag BNR.DE | $9.19B | +2% | 0% | 5% | 14.0× | 0.7% |
| Kemira KEMIRA.HE | $2.47B | -12% | -3% | 8% | 15.8× | 3.9% |
| Ecolab ECL | $84.3B | +21% | +9% | 18% | 33.6× | 20.3% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | HWKN | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +17.0% | -5.9% | highest of 21 |
| 6-month return | -1.2% | -25.4% | 4th highest of 21 |
| Distance from 52-week high | -12.0% | -43.2% | 3rd highest of 21 |
| Revenue growth (TTM) | +9.0% | +12.9% | 9th lowest of 21 |
| Operating margin | 10.8% | 13.5% | 8th lowest of 21 |
| Forward P/E | 34.4× | 17.5× | 5th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 15.9% | 2.9% | 6th most demanding of 16 |
| Growth delivered (Del g) | +12.7% | +8.8% | 7th highest of 16 |
| Hurdle (Req g minus delivered) | +3.2 pp | -6.4 pp | 4th most demanding of 16 |
| ROIC minus cost of capital | +3.7 pp | +2.6 pp | 10th highest of 21 |
| EV / EBITDA | 19.2× | 6.8× | most expensive of 6 |
| Net debt / EBITDA | 1.3× | 1.0× | 3rd most indebted of 6 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Hawkins HWKN | United States | $3.19B | -1% | +9% | 11% | 34.4× | 15.9% | +12.7% |
| Ningbo Shanshan 600884.SS | China | $3.27B | -35% | +30% | 9% | 12.2× | 2.8% | +21.3% |
| Hexpol HPOL-B.ST | Sweden | $3.10B | +19% | -1% | 14% | 15.2× | 2.9% | +7.6% |
| Inner Mongolia Berun Chemical 000683.SZ | China | $3.28B | -27% | +11% | 13% | 13.8× | n/a | n/a |
| Guangzhou Guanggang Gases and Energy 688548.SS | China | $3.02B | -26% | +21% | 20% | 55.4× | n/a | n/a |
| Novoray 688300.SS | China | $3.40B | -39% | +23% | 26% | 49.8× | 45.5% | +22.6% |
| Levima Advanced Materials 003022.SZ | China | $2.93B | -41% | +66% | 10% | 28.4× | n/a | n/a |
| Shanghai Haoyuan Chemexpress 688131.SS | China | $2.87B | +28% | +28% | 13% | 52.3× | 30.5% | +35.2% |
| Luxi Chemical 000830.SZ | China | $2.87B | -32% | -1% | 4% | 11.2× | -2.4% | +10.6% |
| Pangang Group Vanadium & Titanium Resources 000629.SZ | China | $3.60B | -26% | +6% | 4% | 57.3× | 26.1% | -3.4% |
| NOF 4403.T | Japan | $3.60B | -10% | +22% | 17% | 13.6× | -7.4% | +8.4% |
| Do-Fluoride New Materials 002407.SZ | China | $3.62B | -42% | +69% | 7% | 33.9× | 17.3% | +17.5% |
| IMEIK Technology Development 300896.SZ | China | $3.66B | -25% | -7% | 45% | 22.4× | 17.5% | +28.0% |
| Guizhou Chanhen Chemical 002895.SZ | China | $2.76B | -10% | +15% | 18% | 13.5× | 3.3% | +36.1% |
| Hangzhou Oxygen Plant 002430.SZ | China | $3.70B | -16% | +16% | 11% | 19.8× | 2.2% | +8.5% |
| Bluestar Adisseo 600299.SS | China | $3.70B | -34% | +15% | 13% | 11.3× | -9.4% | +7.7% |
| Nifco 7988.T | Japan | $2.71B | +11% | +4% | 14% | 11.9× | -2.4% | +6.6% |
| Mitsubishi Gas Chemical 4182.T | Japan | $3.76B | -32% | +9% | 9% | 10.2× | n/a | n/a |
| Cathay Biotech 688065.SS | China | $3.77B | -23% | +9% | 18% | 34.3× | n/a | n/a |
| Shanghai Bairun Investment 002568.SZ | China | $2.67B | -7% | +8% | 28% | 23.0× | 13.6% | +8.8% |
| Cabot CBT | United States | $3.80B | -5% | +1% | 14% | 11.3× | -2.3% | +1.9% |